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1. Introduction
Kaposi’s sarcoma (KS)-associated herpesvirus (KSHV), also 
known as human herpesvirus 8 (HHV-8), is a gamma herpes-
virus. It is believed to be the etiological agent of KS (Chang et 
al., 1994; Chang and Moore, 1996; Moore and Chang, 2001). 
KSHV is also implicated in the pathogenesis of AIDS-associ-
ated primary effusion lymphoma (PEL, also called body cav-
ity-based lymphoma (BCBL)) and a lymphoproliferative dis-
order known as multicentric Castleman’s disease (Dourmishev 
et al., 2003; Moore and Chang, 2001;  West and Wood, 2003).
As other herpesviruses, KSHV goes through both latency 
and lytic replication cycles. The expression of the KSHV 
replication and transcription activator (RTA) is necessary 
and sufficient for the switch from latency to lytic replication 
(Dourmishev et al., 2003;  West and Wood, 2003). RTA is an 
immediate early gene (Sarid et al., 1998; Sun et al., 1999; 
Zhu et al., 1999) and a sequence-specific DNA-binding pro-
tein. A number of RTA-responsive elements (RRE) were iden-
tified in the transcriptional regulatory regions of different 
subsequently expressed viral genes (Gradoville et al., 2000; 
Lukac et al., 1999; Sakakibara et al., 2001; Saveliev et al., 
2002; Sun et al., 1998; Sun et al., 1999;  Zhu et al., 1999).
In addition to direct DNA binding, the ability of RTA to in-
teract with other factors appears to be necessary for activating 
its transcriptional potential (Gwack et al., 2001; Gwack et al., 
2002; Liao et al., 2003;  Wang et al., 2001). One of the inter-
acting factors is the cellular recombination signal sequence-
binding protein-J kappa (RBP-Jκ) (also known as CBF-1 
and CSL) (Carroll et al., 2006; Liang et al., 2002;  Liang and 
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Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) replication and transcription activator (RTA) is necessary and sufficient for the switch from 
KSHV latency to lytic replication. RTA activates promoters by several mechanisms. RTA can bind to sequences in viral promoters and activate 
transcription. In addition, RTA interacts with the cellular recombination signal sequence-binding protein-J kappa (RBP-Jκ), a transcriptional re-
pressor, converts the repressor into an activator and activates viral promoters via RBP-Jκ. Because RBP-Jκ is required for RTA to activate lytic 
replication, it is important to understand how RTA cooperates with RBP-Jκ protein to activate KSHV lytic replication program. Previously, we 
identified an RTA mutant, RTA-K152E, which has a defect in its direct DNA-binding activity. In this report, the effect of the mutant RTA on 
KSHV activation via RBP-Jκ protein is examined. We demonstrate that RTA-K152E interacts with RBP-Jκ physically and the mutant RTA and 
RBP-Jκ complex binds to target DNA properly in vivo and in vitro. However, the complex of RTA-K152E and RBP-Jκ does not activate tran-
scription. Furthermore, the RTA mutant (RTA-K12E) inhibits cellular Notch-mediated RBP-Jκ activation. These data collectively suggest that 
the complex between KSHV RTA and cellular RBP-Jκ and the subsequent DNA binding by the complex are not sufficient for the activation of 
RBP-Jκ protein. Other factor(s) whether additional cofactor(s) in the complex or the intrinsic conformation of RTA, are predicted to be required 
for the activation of RBP-Jκ protein by RTA. 
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Ganem, 2003). RBP-Jκ is a sequence-specific DNA-binding 
protein and a transcriptional repressor that is involved in the 
Notch signaling pathway.
The Notch signaling pathway regulates cell fate in a vari-
ety of organisms (Bray, 2006;  He and Pear, 2003). Interaction 
of Notch receptors (Notch) with their ligands leads to cleav-
age of the Notch intracellular domain (NICD), which leads to 
nuclear localization of NICD. In the nucleus, NICD associates 
with RBP-Jκ and converts RBP-Jκ from a transcriptional re-
pressor to an activator. Furthermore, the NICD-RBP-Jκ com-
plex activates expression of specific target genes (Bray, 2006; 
He and Pear, 2003).
KSHV RTA can directly bind to RBP-Jκ and the RTA–
RBP-Jκ complex binds to DNA and activates transcription of 
KSHV promoters (Carroll et al., 2006; Liang et al., 2002;  Li-
ang and Ganem, 2003). The KSHV genome contains numer-
ous RBP-Jκ elements suggesting that RBP-Jκ plays an impor-
tant role in viral transcription. The interaction between RTA 
and RBP-Jκ is essential for the switch from viral latency to 
lytic replication in rodent cells (Liang and Ganem, 2003). 
However, it is not clear if interaction between RTA and RBP-
Jκ is the only event that is necessary for activating KSHV lytic 
gene expression.
Previously, we have identified a novel function of RTA, i.e., 
RTA binds to interferon-stimulated response elements (ISRE) 
and activate certain cellular interferon-stimulated genes (ISG) 
(Zhang et al., 2005). In addition, a region in RTA DNA-bind-
ing domain has been identified with certain sequence similar-
ity to the DNA-binding domains of interferon regulatory fac-
tor (IRF) family. Mutation in one conserved amino acid within 
this region (RTA-K152E) reduces the ability of RTA to bind 
to ISRE as well as other RREs. Furthermore, the RTA-K152E 
fails to activate RTA-responsive promoters and to induce viral 
lytic gene expression (Zhang et al., 2005).
In this report, we have further characterized the RTA-
K152E mutant in terms of activating the cellular RBP-Jκ pro-
tein. The mutant RTA is able to interact with RBP-Jκ physi-
cally and the RTA-K152E-RBP-Jκ complex is able to bind to 
DNA in vitro and in vivo. However, the mutant failed to acti-
vate RBP-Jκ protein. Thus, the complex between KSHV RTA 
and cellular RBP-Jκ and their subsequent DNA binding are 
not sufficient for the activation of RBP-Jκ protein.
2. Materials and methods
2.1. Plasmids and antibodies
Expression plasmids of FLAG-tagged RTA and mutant RTA-
K152E were previously described (Zhang et al., 2005). The 
HA-tagged RBP-Jκ expression plasmid was a gift from Dr. 
Paul Ling (Baylor College of Medicine). FLAG-tagged RBP-
Jκ expression plasmid and the reporter construct containing 
3× RBP-Jκ binding site were gifts from Drs. Don Ganem and 
Yuying Liang (Liang et al., 2002). The constitutively active 
Notch expression plasmid, pcDNA-3-mNotch-ΔE, was a gift 
from Dr. Franz Oswald (Oswald et al., 2002). CMV-β-gal and 
CMV-GFP expression plasmids were from Clontech. Peptide 
RTA antibody was described (Xu et al., 2007). Tubulin and 
FLAG-antibodies were purchased from Sigma. HA and RBP-
Jκ antibodies were purchased from Santa Cruz.
2.2. Western blot analysis, cell culture, transient transfection 
and reporter assays
Standard western blot analysis was performed as previously 
described (Zhang and Pagano, 1997; Zhang and Pagano, 1999; 
Zhang and Pagano, 2000;  Zhang and Pagano, 2001). 293-Bac 
(a gift from Dr. S.J. Gao) is a human 293 cells derived cell 
line and containing KSHV genome (Zhou et al., 2002). 293-
Bac36 cells were maintained in DMEM plus 10% fetal bovine 
serum (FBS) plus 0.5 mg/ml hygromycin. 293T cells are a hu-
man fibroblast line and were maintained in DMEM plus 10% 
FBS. Effectene (Qiagen) was used for the transfection of these 
cells. The luciferase assays were performed using a kit from 
Promega according to manufacturer’s recommendation.
2.3. Preparation of KSHV stocks and detection of virion DNA
293-Bac36 cells were transfected with the designated expres-
sion plasmids and culture supernatants were harvested 5 days 
later. Virions were pelleted by centrifugation at 100,000 × g 
for 1 h. The pellets were subsequently suspended in 1× PBS 
buffer (1:100 of the volume of the original supernatants). The 
concentrated viruses were then treated by DNase I at 37 °C for 
1 h. DNA was extracted and PCR analyses were carried out 
with primers targeted K14/vGCR region (BC1 KSHV genome 
coordinates: 127,649–127,883). The conditions of the PCR as-
say were established empirically to ensure a linear amplifica-
tion of template DNA within the amplification conditions.
2.4. Chromatin immunoprecipitation (ChIP)
293-Bac36 cells were transfected with various plasmids. One 
day later, ChIP assays were performed using the chromatin 
immunoprecipitation assay kits according to the manufactur-
er’s recommendation (Upstate, Inc.). Anti-FLAG and normal 
rabbit serum (NRS) was used as designated. The DNA ex-
acted from immunoprecipitates was used as template for PCR 
analyses with various primers that amplify MTA- and PAN-
specific products (Wang et al., 2003a;  Wang et al., 2003b). 
PCR products were resolved in 8% polyacrylamide gel.
2.5. Co-immunoprecipitation (Co-IP)
293T cells grown in 10 cm plates were transfected with the 
designated plasmids. Cell extracts were prepared using RIPA 
buffer (1× PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% 
SDS) supplemented with a protease inhibitor cocktail (Roche) 
were incubated with either mouse anti-FLAG monoclonal an-
tibody M2 (Sigma) or anti-HA antibody (Santa Cruz) for 1 h 
on ice. Protein G-sepharose (Pharmacia) was added and the 
incubation continued at 4 °C overnight with gentle rotation. 
Beads were washed three times with 1× PBS buffer and boiled 
in SDS loading buffer and subsequent western blot were es-
sentially the same as described.
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2.6. Electrophoretic mobility shift assay (EMSA)
The probes were obtained by first annealing complementary 
oligonucleotides and then labeling them with (α-32P)dCTP 
(Amersham) using DNA polymerase Klenow fragment (Fer-
mentas). The RBP-Jκ probe was obtained by annealing two 
oligonucleotides, 5′-GATCTGGTGTAAACAC GCCGT-
GGGAAAAAATTTATG-3′ and its complementary stand, 
with GATC at the 5′ end. DNA-binding reactions were per-
formed essentially as described (Liang et al., 2002;  Lukac et 
al., 2001) with the following modifications: the reaction buffer 
contained 10 mM Tris–HCl (pH 7.5), 50 mM NaCl, 5.3 mM 
MgCl2, 1 mM EDTA, 1 μg polydIdC and 4% glycerol and the 
reactions were carried out at 25 °C for 30 min. If an antibody 
was used for a super-shift experiment, 1 μl of the target anti-
body was added into the reaction mixture.
2.7. In vitro transcription and translation
Proteins were synthesized with the TNT coupled transcrip-
tion and translation kit with rabbit reticulocyte lysate (Pro-
mega) according to the manufacturer’s instructions. pcDNA3-
RTA and RTA-K152E (Zhang et al., 2005) and FLAG-RBP-Jκ 
were used for in vitro transcription and translation of target 
proteins. Luc-plasmid was provided by the manufacturer as a 
positive control for the kit.
3. Results
3.1. RTA-K152E binds to cellular RBP-Jκ
The RTA-K152E mutant does not bind DNA efficiently in vi-
tro and fails to activate several KSHV promoter reporter con-
structs or endogenous lytic gene expression (Zhang et al., 
2005). However, it is not known whether RTA-K152E in-
teracts with RBP-Jκ. To test whether RTA-K152E interacts 
with RBP-Jκ, plasmids expressing these proteins were trans-
fected into 293T cells and co-immunoprecipitation assays (co-
IP) were performed. Expression plasmids containing wtRTA, 
RTA-K152E and RBP-Jκ were transfected into 293T cells. 
The transfected RTA and RBP-Jκ were tagged by FLAG or in-
fluenza hemagglutinin (HA) epitope, respectively (see Section 
2 for details). As shown in Figure 1, both wtRTA and RTA-
K152E interacted with RBP-Jκ in co-IP assays. In several ex-
periments, wtRTA and RTA-K152E appeared to interact with 
RBP-Jκ with similar efficiency. In addition, RTA interacted 
with endogenous RBP-Jκ in co-IP assays (data not shown). 
Thus, the RTA-K152E interacted with RBP-Jκ protein in tran-
siently transfected 293T cells. 
3.2. RTA-K152E binds to RBP-Jκ site indirectly in vitro
To test whether the complex between RTA-K152E and RBP-
Jκ interacted with DNA, EMSA was performed with an RBP-
Jκ consensus recognition sequence as a probe. The respective 
proteins were synthesized to similar levels by in vitro tran-
scription and translation (Figure 2B). The expression of RBP-
Jκ was also confirmed by western blot with the anti-FLAG 
antibody (data not shown). Various combinations of in vitro 
translated proteins were used for EMSA with a RBP-Jκ con-
sensus recognition sequence as probe. As shown in Figure 2, 
a specific shifted band representing the RBP-Jκ protein bind-
ing to the RBP-Jκ probe was observed (lane 3). The shifted 
band was competed for by incubating with 50× of a cold wild 
type RBP-Jκ recognition sequence oligonucleotides. In con-
trast, a mutated RBP-Jκ recognition sequence oligonucle-
otides did not compete for binding (data not shown). The RTA 
or RTA-K152E proteins were unable to bind to the RBP-Jκ 
probe directly, which was expected (lanes 4 and 5). Additional 
protein–DNA complexes appeared when RTA, or the RTA-
K152E mutant, was incubated with RBP-Jκ prior to perform-
ing EMSA (lanes 6 and 7). This novel DNA–protein com-
plexes were specific because they disappeared in the presence 
of a RTA antibody (lanes 8 and 9), but were not affected by 
normal rabbit serum (NRS) (lanes 10 and 11). Furthermore, 
the complexes were not present when the RTA antibody was 
mixed with either RBP-Jκ or RTA individually (lanes 12 and 
13). In summary, these results suggested that both wtRTA and 
the RTA-K152E mutant were able to interact with the RBP-
Jκ protein and consequently bind as a complex to a consensus 
RBP-Jκ recognition site. 
3.3. RTA-K152E binds to KSHV DNA in vivo
To test whether a complex between RTA-K152E and RBP-Jκ 
forms in vivo and binds DNA, ChIP assays were performed. 
Figure 1. RTA-K152E interacts with RBP-Jκ. 293T cells were transfected 
with the designated expression plasmids as shown on the top of the figure. Cell 
extracts from these transfected cells were immunoprecipitated (IP) with either 
anti-HA (panel A) or anti-FLAG (panel B). The immunoprecipitates were ana-
lyzed by western blot (WB) using the indicated antibodies. In panel C, whole 
cell lysate was used for western blot analyses. The identity of the respective 
proteins is denoted. 
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The wtRTA or RTA-K152E mutant was transfected into 293-
Bac36 cells, a human 293 derived cell line harboring the 
KSHV genome (Zhou et al., 2002). Expression of the two 
RTA proteins was similar (data not shown, also Figure 5B). 
Anti-FLAG antibody was used for ChIP analyses because this 
approach avoided the endogenous auto-regulation of RTA ex-
pression (Deng et al., 2000;  Sakakibara et al., 2001). Two 
KSHV promoter regions, MTA and PAN, were used as tar-
Figure 2. RTA-K152E binds to DNA indirectly via RBP-Jκ. (A) RTA-K152E binds to DNA via RBP-Jκ. The RBP-Jκ probe was labeled with (α-32P)-dCTP. In 
vitro transcribed and translated proteins were used for EMSA analyses in various combinations as shown on the top of the gel. Normal rabbit serum (NRS) and 
rabbit polyclonal anti-RTA were used for blocking the complex formations. Specific protein–DNA complexes are as shown. (B) Expression levels of RTA. Equal 
amounts of in vitro transcribed and translated reticulocyte lysates containing RTA and RTA-K152E proteins were used for western blot analyses. The identity of 
proteins is as shown. (C) RTA-K152E binds to KSHV genomic DNA in vivo. 293-Bac36 cells were transfected with pcDNA3, RTA or RTA-K152E expression 
plasmid. Twenty-four hours later, FLAG antibody was used for ChIP analyses to detect in vivo DNA-binding activities of RTA proteins derived from input plas-
mids. Primers for MTA and Pan promoter regions were used to amplify the DNA from immunoprecipitates. The identity of DNA is as shown. The genomic DNA 
was used as positive control. Input DNA represents the PCR amplification from same amounts of input lysates without immunoprecipitations. PCR amplification 
of immunoprecipitates from normal rabbit serum (NRS) is also shown as controls. 
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gets for amplifying DNA from the immunoprecipitates as de-
scribed (Wang et al., 2003a;  Wang et al., 2003b). As shown in 
Figure 2C, both the MTA and Pan promoter regions were am-
plified from immunoprecipitates regardless of whether wtRTA 
or RTA-K152E was transfected. However, PCR amplification 
resulted in the similar amounts of target DNA from the immu-
noprecipitates by normal rabbit serum (NRS). In addition, in-
put DNA before immunoprecipitations was similar. These re-
sults collectively suggested that both wtRTA and RTA-K152E 
interacted with KSHV genomic DNA in 293T cells with sim-
ilar efficiencies, which was in agreement with the EMSA data 
(Figure 2A).
3.4. The RTA-K152E does not activate transcription, in spite 
of interacting with RBP-Jκ
wtRTA interacts with the RBP-Jκ protein and consequently 
activates specific viral promoters (Carroll et al., 2006; Li-
ang et al., 2002;  Liang and Ganem, 2003). To test whether 
the RTA-K152E mutant was capable of trans-activating vi-
ral transcription, the ability of the RTA-K152E mutant to ac-
tivate a minimal promoter construct containing multiple RBP-
Jκ consensus binding sequences was examined (Liang et al., 
2002). The promoter reporter construct and RTA expression 
plasmids were co-transfected into 293T cells and reporter ac-
tivities measured. As shown in Figure 3A, wtRTA was able 
to activate the minimum promoter reporter construct con-
taining RBP-Jκ-binding sites approximately 15-fold in a 
dose-dependent fashion. In sharp contrast, the RTAK152E 
failed to activate the reporter construct above basal levels. 
The mutant RTA was expressed in relatively higher amounts
than wtRTA (Figure 3B). Because comparable β-galactosidase 
activities were observed between wtRTA and the mutant RTA 
expressing cells, there was no apparent toxicity associated 
with mutant RTA expressed cells. In addition, same results 
could be obtained with the similar levels of RTAs by manip-
ulation of transfected plasmid amounts (data not shown). All 
these results suggested that RTA-K152E was unable to con-
vert RBP-Jκ protein into a transcriptional activator. 
3.5. RTA-K152E interferes intracellular Notch signaling
To test the physical interaction between the mutant RTA and 
RBP-Jκ from another direction, we examined if RTA-K152E 
affects the Notch signaling pathway. Because RBP-Jκ is in-
volved in the Notch signaling pathway, we suspect that over-
expression of the RTA-K152E mutant would alter the Notch 
signaling pathway by interacting and sequestering the RBP-
Jκ protein. A constitutive active mutant of Notch was used for 
these studies. As shown in Figure 4, the constitutively active 
Notch mutant activated the RBP-Jκ reporter construct by at 
least 20-fold in a dose-dependent fashion. The expression of 
wtRTA-stimulated the RBP-Jκ reporter construct more than 
40-fold. The co-expression of wtRTA with activated Notch 
did not further stimulate the RBP-Jκ reporter construct activ-
ity. Although wtRTA binds to RBP-Jκ but because wtRTA it-
self activates RBP-Jκ, no effect of wtRTA on Notch signaling 
pathway is anticipated. In sharp contrast, the RTA-K152E mu-
tant interfered with the ability of Notch to activate the RBP-
Jκ promoter construct. Due to the fact that mutant RTA inter-
acts with RBP-Jκ, these data suggest that mutant RTA inhibit 
the Notch signaling and possibly through sequestering RBP-
Jκ. These data indirectly support the physical interaction be-
tween the mutant RTA and RBP-Jκ in vivo. 
Figure 3. RTA-K152E fails to activate RBP-Jκ protein. (A) RTA-K152E fails 
to activate the RBP-Jκ protein. 293T cells were transfected with 3× RBP-Jκ-
Luc reporter constructs along with CMV-β-gal, RTA or RTA-K152E expres-
sion plasmids as shown on the top of the panel. Luciferase activity was nor-
malized by β-galactosidase activity. The fold activation of promoter constructs 
in response to K-RTA is shown with standard deviations. The results from one 
representative experiment in triplicates were shown. (B) Expression levels of 
RTA and its mutant. Western blotting with FLAG antibody was performed. 
The cell lysate from transfected cells are indicated. The identity of proteins is 
as shown. Lane numbers denote the same treatment as shown in panel A. 
Figure 4. RTA-K152E interferes intracellular Notch signaling. Various 
amounts of constitutively active Notch were transfected into 293T cells with a 
fixed amount of the other plasmids as shown on the top of the panel. Lucifer-
ase activity was normalized by β-galactosidase activity. The fold activation of 
promoter constructs was shown with standard deviations. The results from one 
representative experiment in triplicates were shown. 
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3.6. RTA-K152E fails to induce KSHV virion production
We have previously shown that RTA-K152E fails to activate 
KSHV lytic genes through direct DNA binding (Zhang et al., 
2005). In this report, data in Figure 3 and Figure 4 suggested 
that RTA-K152E would not activate genes mediated by RTA–
RBP-Jκ-complex through an indirect DNA-binding mecha-
nism. Because RTA activates viral promoters through both 
direct and indirect DNA-binding mechanism, it is thus nec-
essary to directly test if the mutant fails to induce a complete 
KSHV lytic replication. KSHV virion production is the final 
step of the lytic replication and we thus measured the produc-
tion of the virions in response to RTA expression. The expres-
sion plasmid of wtRTA or RTA-K152E mutant was transfected 
into 293-Bac36 cells (Zhou et al., 2002). The expression lev-
els of RTAs were similar in cell lysates (Figure 5B). The me-
dia were collected 5 days later and virus particles in the media 
were concentrated and digested by DNase. Semi-quantita-
tive PCR was subsequently used to detect the DNase-resis-
tant KSHV genomic DNA packaged in virions. The condition 
of the PCR was established empirically for a linear amplifica-
tion of template DNA. As expected, wtRTA induced the ac-
cumulation of DNase-resistant KSHV genomic DNA (Fig-
ure 5A). In contrast, DNase-resistant genomic DNA was not 
detected following transfection of 293-Bac36 cells with the 
RTA-K152E mutant. Thus, RTA-K152E mutant was unable to 
induce KSHV virion production. 
4. Discussion
Numerous studies have indicated that RTA activates target 
promoters by directly binding to DNA and by indirectly bind-
ing via interaction with various cellular factors (Dourmishev 
et al., 2003;  West and Wood, 2003). RBP-Jκ plays an essen-
tial role in RTA-mediated KSHV lytic replication. In this re-
port, we have addressed whether the RTA-RBP-Jκ interaction 
is sufficient for the lytic replication of KSHV.
Notch signaling is well conserved in evolution. Many vi-
ruses usurp this signaling pathway for their own benefits 
(Hayward, 2004). However, none of them, including KSHV, 
can be completely replaced by cellular Notch signaling 
(Chang et al., 2005). RTA must have its own specific prop-
erties to usurp Notch signaling pathway. RTA-K152E has a 
mutated DNA-binding domain and has a defect in its direct 
DNA-binding activity as determined by EMSA with the puri-
fied protein. Like wtRTA, RTA-K152E interacted with RBP-
Jκ physically and the mutant–RBP-Jκ complex was able to 
bind to DNA (Figure 1 and Figure 2). However unlike the 
wtRTA, the physical interaction between the RTA mutant and 
RBP-Jκ failed to activate the RBP-Jκ protein. The mutant 
further inhibited the function of a constitutively active Notch 
mutant (Figure 4). Moreover, as an extension to our previ-
ous publication, the RTA-K152E failed to induce KSHV vi-
rion accumulation (Figure 5). Thus, two apparently contra-
dicting properties of RTA-K152E have clearly emerged from 
our data: (1) RTA-K152E failed to activate the RBP-Jκ pro-
tein; but (2) the mutant had similar capabilities to interact 
with RBP-Jκ and furthermore to bind to DNA indirectly via 
the interaction. The two properties collectively suggest that 
the interaction between RTA and RBP-Jκ and their subse-
quent DNA binding by the complex were not sufficient for 
the initiation of lytic replication of KSHV.
It remains unclear how the mutation in the DNA-binding 
domain of RTA had such a profound effect on RTA functions. 
Because of the known defect in this mutant, our results might 
suggest that direct DNA-binding activity of RTA might be re-
quired to convert the RBP-Jκ protein from a repressor into an 
activator. Since RTA interacts with many cellular factors (Car-
roll et al., 2006; Gwack et al., 2001; Gwack et al., 2002; Li-
ang et al., 2002; Liang and Ganem, 2003; Liao et al., 2003; 
Wang et al., 2001), it is possible that the K152E mutation af-
fects the binding of an unknown cellular factor. It is also pos-
sible that the mutation at the DNA-binding domain (K152E) 
has changed RTA conformation from a transcriptional activa-
tor into a repressor. Based on the structure and function analy-
sis of RTA (Dourmishev et al., 2003;  West and Wood, 2003), 
the activation domain is located at the C-terminal region of the 
RTA. Thus, it is hard to imagine that a single point mutation at 
the N-terminus would affect the C-terminal activation domain.
In summary, this report examined the physical interaction 
between RTA and RBP-Jκ with respect to the activation of the 
RBP-Jκ protein and the activation of KSHV lytic replication. 
Our data demonstrated that the physical interaction between 
KSHV RTA and RBP-Jκ and their subsequent DNA binding 
by the complex were not sufficient to activate RBP-Jκ and to 
induce KSHV lytic replication. Other factor(s), whether it is 
the intrinsic property of RTA or its interaction with other co-
factors, are predicted to be required for the activation of RBP-
Jκ protein by RTA. These findings have provided a new in-
sight into the structure and functions of RTA. 
Figure 5. RTA-K152E fails to induce KSHV virion production. (A) RTA-
K152E fails to induce DNase-resistant KSHV genomic DNA packaged into 
virions. The media from pcDNA3, RTA or RTA-K152E transfected 293-Bac36 
cells were collected and KSHV viruses were concentrated by centrifugation. 
After DNase I digestion, PCR analyses were used for detecting KSHV ge-
nomic DNA. The genomic DNA isolated from 293-Bac36 was used as posi-
tive control. (B) Expression of RTA and its mutant in transfected cells. Lysate 
from pcDNA3, RTA, or RTA-K152E transfected 293-Bac36 cells were used 
for western blot analysis with FLAG and tubulin antibodies. The identity of 
the respective proteins is denoted. 
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